Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
3-V Biosciences Inc Biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases. |
United States | 10 Jul 2019 | Series B Initial investment. Round participant. Active |
|
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | 7 Oct 2024 | Series A Initial investment. Round participant. Active |